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Abstract
Cancer-testis (CT) genes are expressed in various cancers but not in normal tissues other than in cells of the germline.
Although DNA demethylation of promoter-proximal CpGs of CT genes is linked to their expression in cancer, the
mechanisms leading to demethylation are unknown. To elucidate such mechanisms we chose to study the Caco-2
colorectal cancer cell line during the course of its spontaneous differentiation in vitro, as we found CT genes, in particular
PAGE2, -2B and SPANX-B, to be up-regulated during this process. Differentiation of these cells resulted in a mesenchymal-to-
epithelial transition (MET) as evidenced by the gain of epithelial markers CDX2, Claudin-4 and E-cadherin, and a concomitant
loss of mesenchymal markers Vimentin, Fibronectin-1 and Transgelin. PAGE2 and SPAN-X up-regulation was accompanied
by an increase in Ten-eleven translocation-2 (TET2) expression and cytosine 5-hydroxymethylation as well as the
disassociation of heterochromatin protein 1 and the polycomb repressive complex 2 protein EZH2 from promoter-proximal
regions of these genes. Reversal of differentiation resulted in down-regulation of PAGE2, -2B and SPANX-B, and induction of
epithelial-to-mesenchymal transition (EMT) markers, demonstrating the dynamic nature of CT gene regulation in this model.
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Introduction
Cancer-testis (CT) or cancer-germline genes are expressed in
tumors originating from various tissues, as well as in normal
germline and trophoblast cells, but are generally silent in other
normal tissues of the adult [1–3]. More than 100 different CT
genes can be grouped according to homology into families [2].
Despite the lack of sequence similarity between CT genes from
different families, re-expression of all CT genes in tumors has been
associated with demethylation of CpG residues within their
promoter-proximal regions [4]. This shared mechanism of
expression regulation is most likely the reason for their coordinate
expression in cancer [5–7]. However, the exact mechanism by
which DNA demethylation occurs at CT gene promoter-proximal
regions in cancers is unknown. CT genes show mostly a
heterogeneous expression pattern in tumors [8–10]; in contrast
to their expression in testis, which is demarcated and orderly [11].
A study in which stem-like and non-stem like cells of breast cancer
were selectively killed, revealed that CT gene expression is
generally a feature of more differentiated, non-stem cells [12].
Similarly, in melanoma, a subgroup of cells with more epithelial
features express CT genes, when cells with mesenchymal features
don’t [13]. Interestingly, melanoma cells can switch between these
two classes in vivo, suggesting that tumor heterogeneity, as defined
by CT gene expression, might represent a transitional phase
similar to the switch between epithelial and mesenchymal
phenotypes. Indeed, mesenchymal-to-epithelial transition (MET)
is associated with the induction of CT gene expression [14]. To
define mechanisms involved in regulating CT gene expression in
cancer and during MET, we chose to study the Caco-2
spontaneous differentiation model which demonstrates features
of MET and EMT during differentiation and de-differentiation,
respectively. Our data reveal that the dynamic regulation of the
two CT genes, PAGE and SPANX-B in this model system,
involves alterations of polycomb repressive complex 2 (PRC2) and
heterochromatin protein 1 (HP1) occupancy within their promot-
er-proximal regions, with concordant changes in TET expression
and cytosine hydroxymethylation (hmC) levels.
Methods
Cell lines, induction of differentiation and
de-differentiation
The Caco-2 cell line was obtained from the SAP Enstitusu
(Ankara, Turkey). HCT116 (colorectal) and Mahlavu (hepatocel-
lular) cancer cell lines were obtained from LGC Standards,
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Figure 1. Up-regulation of CT genes in parallel to MET in the Caco-2 SD model. Relative mRNA expression of CT genes (PAGE2, -2B and
SPANXB) (A), epithelial genes (E-cadherin (CDH1), claudin 4(CLDN4), CDX2) (B), and mesenchymal genes (fibronectin 1 (FN1), vimentin (VIM), transgelin
(TAGLN)) (C) as determined by quantitative PCR at days 0, 10, 20 and 30 post-confluence. Data represent average of two experiments. Change in
expression levels for all genes between days 0 and 30 is statistically significant (P,0.0001, by two way ANOVA with Tukey’s post hoc test).
doi:10.1371/journal.pone.0107905.g001
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Figure 2. SPANX-B and vimentin expression are mutually exclusive in differentiating Caco-2 cells. Immunofluorescent staining of
differentiating Caco-2 cells with DAPI counterstaining reveals a gradual increase in nuclear SPANX-B (green) with a concomitant decrease in
cytoplasmic vimentin expression (red); (206magnification) (A). Less than 1% of SPANX-B positive cells showed staining for vimentin on day 0 (B).
doi:10.1371/journal.pone.0107905.g002
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Middlesex, UK. A lung cancer cell line (SK-LC-17) was from the
Memorial Sloan Kettering Cancer Center, NY, USA. Caco-2 cells
were grown in EMEM and others in RPMI, supplemented with
20% FBS, 2 mM L-glutamine, 0.1 mM non-essential amino acids,
1.5 g/L sodium bicarbonate and 1 mM sodium pyruvate. All cell
culture media and supplements were purchased from Biochrom
AG, Berlin, Germany. The first day cells reached confluence was
designated day 0. Cells grown in parallel cultures were used to
determine phenotypic changes at days 0, 5, 10, 20 and 30, post-
confluence. Additional measures of differentiation for cells used in
this study have been reported elsewhere [15]. To induce
dedifferentiation, cells at the 20th day of differentiation were
detached and replated at about 50% confluence and RNA and
protein were harvested 5 days following replating.
In silico analysis of CT and EMT gene expression
Expression data contained within GSE1614 [16] was GC-RMA
normalized using GeneSpring v. 11.0. CT gene expression was
analyzed based on 31 probesets in corresponding to 23 CT genes
from 7 families (Figure S2). An interpretation was generated with
an entity list composed of EMT related genes as defined by
Loboda et al. [17], at three different time points. Genes for
validation were selected among those for which significant
differences of expression (p,0.05) was observed by one way
ANOVA test and Bonferroni FWER correction, when proliferat-
ing cells were compared to those at day 15.
Quantitative RT-PCR
Total RNA was isolated using the Trizol reagent (Ambion,
Foster City, CA, USA) and treated with DNAse I (Ambion, Foster
City, CA, USA). 200 ng of RNA was reverse transcribed using
Revert-Aid first strand cDNA synthesis kit (Thermo Fisher
Scientific, Boston, MA, USA). PCR reactions were performed
using an ABI 7500 thermal cycler (Applied Biosystems, Carlsbad,
CA, USA). All reactions were performed according to manufac-
turer’s recommendations. TaqMan Gene Expression Assays
(Applied Biosystems, Carlsbad, CA, USA) were used for the
following: GAPDH (4352934E), SPANX-B (Hs02387419_gH),
PAGE2 and -2B (Hs03805505_mH), GAGE (Hs00275620_m1),
SSX4 (Hs023441531_m1), NY-ESO-1 (Hs00265824_m1), and
MAGE-A3 (Hs00366532_m1). SYBR Green master mix with
ROX reference dye (Applied Biosystems, Carlsbad, CA, USA) was
used to determine CDH1, CDX2, CLDN4, VIM, FN1 and
TAGLN expression (Table S1). Cycling conditions for these
assays were 50uC for 2 min., 95uC for 10 min., followed by 40
cycles of 94uC for 15 sec., 60–65uC for 1 min. Relative expression
was calculated by the DDCt method [18]. All samples were
analyzed in triplicates and all experiments were repeated at least
twice.
Promoter methylation analysis
Genomic DNA was isolated by Proteinase K treatment,
following a phenol-chloroform extraction protocol. Bisulphite
treatment of 200 ng genomic DNA was performed using Zymo
DNA Methylation Gold Kit (Zymo Research, Irvine, CA, USA).
Bisulphite modified DNA was stored at 220uC and used for PCR
within 2 months. Two rounds of DNA amplification were
performed using One Taq Hot Start DNA polymerase (New
England Bioscience/NEB, Ipswich, MA, USA) using a Perkin
Elmer 9700 thermal cycler (Applied Biosystems, Carlsbad, CA,
USA). Primers used are given in Table S1. PCR products were
gel extracted using the QIAGEN gel extraction kit (Qiagen,
Hilden, Germany) and cloned into pCR2.1 (Invitrogen, Carlsbad,
CA, USA). Plasmid DNA was purified using the QIAprep Spin
Miniprep Kit (Qiagen, Hilden, Germany) from at least ten clones,
and sequence analyzed by IONTEK (Istanbul, Turkey).
5-hydroxymethyl cytosine analysis
Caco-2 genomic DNA (gDNA) was sheared by probe sonication
(30 sec. on, 30 sec. off, 5 cycles) to obtain 200–600 bp. fragments
assessed by 1% agarose gel electrophoretic analysis. Immunopre-
cipitation was performed using the hMEDIP kit (Abcam, Cam-
bridge, UK) according to manufacturer’s instructions. 5 pg of
control DNA was spiked into 500 ng of gDNA to use as an
internal control. Positive and negative controls of the kit were
included in all experiments. 2 ml from the eluted DNA was used as
template for quantitative RT-PCR using 2 X SYBR Green master
mix with ROX reference dye (Applied Biosystems, Carlsbad, CA,
Figure 3. Nuclear co-localization of CDX2 and SPANX-B in
differentiating Caco-2 cells. Immunofluorescent staining of differ-
entiating Caco-2 cells with DAPI counterstaining reveals overlapping
SPANX-B (Alexa Fluor 488: green) and CDX2 (Alexa Fluor 568: red)
expression; (206magnification) (A). More than 60 to 80% of the cells
show double-labeling when analyzed quantitatively (B).
doi:10.1371/journal.pone.0107905.g003
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USA) with the primers given in Tables S1 and S2. Primer
efficiencies were controlled. Cycling conditions were 50uC for
2 min., 95uC for 10 min. followed by 40 cycles of 94uC for 15 sec.,
60uC for 1 min. Shared genomic DNA was included in
quantitative RT-PCR to calculate % input.
Immunofluorescence microscopy
Cells attached to glass slides by centrifugation using the
Shandon CytoSpin3 (Thermo Scientific, Waltham, MA, USA)
were immediately fixed in 2% formaldehyde/PBS at room
temperature for 15 min. Fixed cells were permeabilized in 0.2%
Triton X-PBS for 10 min. followed by blocking with 1% BSA in
0.1% PBS-Tween for 1 hour. Incubations with the primary
antibody, diluted at 1:50, were performed overnight at 4uC.
Secondary antibody was added at 1:200, following washing in
0.1% PBS-Tween for 5 min. for 3 times, and incubated with cells
for 45 min. at room temperature (see Table S3 for the complete
antibody list). Stained samples were mounted with mounting
medium (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
containing DAPI solution. Cell lines used as positive controls were
Mahlavu (PAGE-2,-2B and SPANXB), MDA-MB 231 (VIM),
MCF-7 (TAGLN) and SW620 (CDX2, FN1). Negative controls
were combinations of primary antibodies with un-related second-
ary antibodies. All images were obtained using an AxioCam
MRc5 image capture device (Carl Zeiss, Oberkochen, Germany).
Western analysis
Cell lysates (extracted with RIPA buffer) separated on 4–12%
Novex Bis-Tris SDS gels (Invitrogen, Carlsbad, CA, USA) were
transferred to Immobilon-PSQ membranes (Millipore Corp.
Bedford, MA, USA) with an Invitrogen western blotting system
(Invitrogen. Carlsbad, CA, USA). Following blocking with 5%
milk powder in 0.02% PBS-T, blots were incubated with primary
antibody overnight at 4uC. Primary antibody dilutions were
1:1000 for CDX2, fibronectin, vimentin and transgelin, 1:2500 for
b-actin and 1:100 for SPANX-B and PAGE-2,-2B antibodies.
HRP conjugated secondary antibody (Abcam, Cambridge, UK)
was used at a 1:5000 dilution and incubated at room temperature
for 1 hour. Signals were detected using the ECL luminescence
assay (BioRad, Hercules, CA, USA).
Figure 4. Bisulfide sequencing of PAGE2, -2B and SPANX-B promoter-proximal regions. Filled and empty circles represent methylated and
unmethylated cytosines, respectively. %methylation within each analysed region, based on the 10 clones sequenced is indicated. CpG residues proximal
to PAGE2, -2B and SPANX-B promoters during Caco2 differentiation at days 0, 10 and 30 reveals no statistically significant change (by one-way ANOVA).
doi:10.1371/journal.pone.0107905.g004
Figure 5. Increased hydroxymethylation of PAGE2 and SPANX-B
during Caco-2 spontaneous differentiation. CHIP experiments
using an anti-hmC antibody and primers corresponding to +31 to +182
and +68 to +184 bp from the transcription start site of the PAGE2 and
SPANX-B genes, respectively. P values (one-way ANOVA) are 0.001 and
0.07 for PAGE2 and SPANX-B, respectively.
doi:10.1371/journal.pone.0107905.g005
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Chromatin Immunoprecipitation
Chromatin Immunoprecipitation (ChIP) was performed as
previously described [15]. Briefly, formaldehyde cross-linked cell
constituents were precipitated by proten A sepharose beads
coupled to antibodies against EZH2, HP-1 or H3K27m3 (Abcam,
Cambridge, UK), as well as isotype-specific control. Precipitated
DNA was amplified using primers specific for PAGE2, -2 or
SPANX-B promoter sequences (Tables S1 and S2), following
de-crosslinking.
Results
CT gene expression during Caco-2 spontaneous
differentiation (Caco-2 SD)
The undifferentiated colorectal cancer cell line Caco-2 under-
goes enterocytic differentiation upon reaching confluence in vitro
[19,20]. Gradual differentiation has been observed up to 30 days
post-confluence as evidenced by the up-regulation of various
differentiation-associated genes including sucrase-isomaltase, alka-
line phosphatase and carcinoembryogenic antigen (CEA), (Figure
S1) [15]. An in silico analysis of CT gene expression as defined by
31 probesets in the GSE1614 dataset, which contains gene
expression data for the Caco-2 SD model obtained during
differentiation (proliferating (2nd day), post-proliferation-undiffer-
entiated (8th day), and post-proliferation-differentiated (15th day))
[16], revealed modest up-regulation of almost all CT genes during
differentiation (Figure S2). We chose to validate the change in
expression of six CT gene/gene families by quantitative RT-PCR
in differentiating Caco-2 cells in vitro. GAGE, MAGE-A3, NY-
ESO-1 and SSX4 transcripts were undetectable on the first day of
confluence, as well as at later time points (data not shown).
However, significant up-regulation of PAGE2 (2 and 2B), and
SPANX-B genes was evident (Figure 1).
PAGE2 and SPANX-B expression follow MET in the Caco-2
SD model
Spontaneous differentiation of Caco-2 in vitro has been
reported to result in MET [21,22]. To determine if this occurred
in parallel to the up-regulation of PAGE2 and SPANX-B, we
analyzed the GSE1614 dataset for the expression of genes
representing EMT in colorectal cancer [17], and selected 6 genes
to be validated in our model. Analysis of mRNA and protein
expression of these revealed a decrease in mesenchymal genes
(vimentin, fibronectin 1 and transgelin) with a concomitant
increase in expression of epithelial genes (CDX2, claudin-4 and
E-cadherin) as the cells differentiated, demonstrating that the
increase in CT gene expression occurs simultaneously with MET
in this model (Figure 1 & Figure S3).
PAGE2, SPANX-B and EMT gene expression in situ
To study if the changes in protein expression of CT and EMT
genes occurred simultaneously in the same cells, we performed
double immunofluorescence staining during differentiation. A
gradual loss of mesenchymal markers was observed as cells
differentiated, with a concomitant increase in epithelial genes and
CT genes. SPANX-B and PAGE-2 were frequently co-expressed
with the epithelial marker CDX2 in the same cells but almost
never with VIM or FN1 (Figures 2, 3 and Figures S4, S5, S6,
S7).
PAGE2 and SPANX-B expression correlates with increased
hmC and ten-eleven translocation methylcytosine
dioxygenase (TET) up-regulation
Expression of all CT genes studied thus far including PAGE2
and SPANX-B have been associated with the demethylation of
CpG residues within regions proximal to the transcription start site
[1,2,23–26]. In this line, both PAGE2 and SPANX-B can be up-
regulated by 5-aza 29-deoxycytidine treatment (Figure S8).
Figure 6. TET expression during Caco-2 SD. mRNA of all three TET genes increase gradually during Caco-2 SD (A). An increase in only a 25 kD
version (B), but not the full-length TET2 protein (C) occurs simultaneously with the increase in mRNA. BAPTA-AM treatment results in a modest
decrease in the 25 kD TET2 protein, with the generation of a larger mw version (D). P values, as determined by one-way ANOVA, are 0.03, 0.01, and
0.07, for Tet1, Tet2, and Tet3, respectively.
doi:10.1371/journal.pone.0107905.g006
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However, bisulfite sequencing of promoter-proximal regions of
both PAGE2 and SPANX-B revealed no differences at different
stages of Caco-2 SD (Figure 4). As bisulfite sequencing is unable
to distinguish methyl cytosine (mC) from hmC, we asked whether
the change in CT gene expression could be related to altered
hmC/mC ratios within their promoters. In fact, chromatin
immunoprecipitation (ChIP) with a hmC specific antibody
revealed an increase in hmC during differentiation in both
PAGE2 and SPANX-B2 promoters (Figure 5). We next asked if
the increase in hmC was related to an increase in TET1, -2, and -3
expression as these proteins are responsible for converting mC to
hmC [27,28]. Indeed, the increase in hmC of PAGE2 and
SPANX-B2 promoters were correlated with an up-regulation of
TET2 mRNA expression, together with modest increases in TET1
and 3 (Figure 6A). Double immunofluorescence staining revealed
that the majority of cells expressing PAGE2 or SPANX-B were
positive for TET2 staining; indicating these two events occurred in
the same cells (Figure 7). It is therefore, likely that the increase in
TET2 expression causes increased hmC in these genes. Interest-
ingly, only a low molecular weight translation product (,25 kD) of
TET2 was increased in the differentiating cells, when no clear
difference in levels of the full-length TET2 protein was observed
(Figure 6B & C). The peptide used for generating the
commercial TET2 antibodies could specifically inhibit recognition
of the 25 kD product confirming its identity with TET2 (data not
shown). TET2 has recently been shown to undergo proteolytic
cleavage by calpain 1 and 2, generating a 25 kD product in vitro
[29]. To test if a cation-dependent protease is responsible for the
generation of the 25 kD protein, we treated differentiating cells
with an intracellular Ca2+ chelator (BAPTA-AM). This resulted in
Figure 7. Overlapping TET2 and CT gene expression in differentiating Caco-2 cells. Double immunofluorescence staining for TET2
(Alexafluor 568: red) and SPANX-B or PAGE2 (Alexafluor 488: green) with DAPI counterstaining 20 days post-confluence show overlapping nuclear
expression Magnification: 406 (A). More than 95% of cells expressing PAGE2 or SPANX-B were also positive for TET2 staining (B).
doi:10.1371/journal.pone.0107905.g007
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a modest reduction in the 25 kD TET2 protein with the
concomitant generation of a larger molecular weight product
(,50 kD), suggesting that the 25 kD TET2 protein is a Ca+2
dependent protease cleavage product with a 50 kD intermediate
(Figure 6D).
EZH2 and HP-1 occupancy of PAGE2 and SPANX-B
promoter proximal regions decrease during
differentiation
Hydroxymethylation has been reported to prevail in promoters
with dual H3K4 and H3K27 trimethylation that also bind PRC2
proteins [30]. The PRC2 complex protein EZH2 has been implied
in the repression of GAGE, another CT gene [31]. We therefore,
asked whether increased hmC within CT gene promoters resulted
in altered EZH2 binding to the same sites. Indeed, ChIP
experiments demonstrated a decrease in EZH2 occupancy, as
well as a decrease in H3K27m3 in both PAGE2 and SPANX-B
promoters during Caco-2 SD (Figure 8). The PRC2 component
SUZ12 has been reported to regulate H3K9 methylation and in
turn, heterochromatin protein 1 (HP1a) binding. In fact, we
observed a simultaneous decrease in HP1 binding to both PAGE2
and SPANX-B promoters during differentiation, that correlated
with PAGE2 and SPANX-B upregulation (Figure 8). Thus, our
data suggest that both PRC2 and HP-1 contribute to maintaining
PAGE2 and SPANX-B in a transcriptionally silent state when the
Figure 8. Chromatin modifications within PAGE2 and SPANX-B during Caco-2 differentiation. CHIP analysis of PAGE2, -2B and SPAN-X
transcription-start site-proximal regions reveals decreased EZH2 occupancy and H3K27m3 (A), as well as decreased HP-1 binding during
differentiation (B). P values (one-way ANOVA) calculated for PAGE2B, PAGE2, and SPANX-B, are ,0.001, 0.02, and 0.001 for EZH2; 0.003, ,0.001, and
,0.0001 for H3K27m3; and 0.001, ,0.001, and ,0.001, for HP1, respectively.
doi:10.1371/journal.pone.0107905.g008
Figure 9. De-differentiation induced EMT and down-regulation of CT and TET genes. De-differentiation induced by growth under non-
confluent conditions indicated by decreased sucrose isomaltase (SI) mRNA levels (A), leads to down-regulation of CDX2, PAGE2, -2B and SPANX-B, with
concomitant up-regulation of TGLN (B). TET1 and -2 mRNAs are also down-regulated during de-differentiation (C).
doi:10.1371/journal.pone.0107905.g009
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cells have a mesenchymal phenotype, and that increased TET2
expression and hmC mediated transcriptional activation are
related to PRC2 and HP-1 dissociation from the promoters of
these CT genes during differentiation.
PAGE2 and SPANX-B up-regulation is reversed during EMT
We hypothesized that if the epigenetic alterations underlying
CT gene expression happened in parallel to MET, that this
process could be reversed if cells entered EMT. To test this
hypothesis, differentiated Caco-2 cells were detached and allowed
to proliferate for 5 days. This resulted in their rapid de-
differentiation as evidenced by down-regulation of SI. De-
differentiated cells down-regulated PAGE2 and SPANX-B, as
well as CDX, as they up-regulated TAGLN, in line with ongoing
EMT (Figure 9). Although transcription of all three TET genes
decreased during de-differentiation (Figure 9), we did not observe
a decrease in hmC during this period (data not shown). We,
therefore, conclude that the up-regulation of CT gene expression
is reversible in this model.
Discussion
Previous studies revealed that CT gene expression correlated
with an epithelial rather than a mesenchymal phenotype, and
showed the up-regulation of CT genes during MET [12,14]. To
our knowledge, this is the first report describing alterations in
several epigenetic mechanisms within promoters of two CT genes
during MET-like differentiation concordant with a dynamic
change in gene expression. As bisulfite sequencing of PAGE2
and SPANX-B promoters revealed no change upon differentia-
tion, the increased hmC must strictly involve methylated CpG
residues. This is in line with the fact that TET enzymes are
responsible for the conversion of 5-methyl cytosine to 5-
hydroxymethyl cytosine [27,28]. Conversion of hmC to mC is a
far more complex process and might not happen with similar
kinetics [32,33]. This is likely the reason why we did not observe a
change in hmC during the 5 day de-differentiation process of
Caco-2 cells despite the decrease observed in global TET levels.
Our finding that PAGE2, SPANX-B and TET2 induction is
reversible is similar to another study in embryonic stem cells where
Vitamin C was shown to induce TET2 expression, which in turn,
resulted in up-regulation of CT genes. Both events were reversible
upon Vitamin C withdrawal [34].
Although hydroxymethylation within gene promoters has been
reported to decrease during differentiation of normal cells, a recent
study revealed that about 20% of all modified cytosines in most
CT genes in human brain, where they are not expressed, consist of
hmC [35]. Up-regulation of TET2 expression in cancer has been
associated with MET [36,37]; and therefore, a more differentiated
state [30]. Similar to the inverse correlation between EZH2 and
CT/TET2 expression we report here, others have shown EZH2
and TET enzymes to repress and induce differentiation of
neuronal precursors, respectively [38]. CT genes are up-regulated
during the initial stages of development in the human embryo, but
decrease as tissues differentiate further [39]. As adult colon tissue
does not show PAGE2 or SPANX-B expression (data not shown),
had Caco-2 cells the capability of differentiating further, both
genes might have been down-regulated completely. On the other
hand, the fact that we could not demonstrate up-regulation of
GAGE, MAGE-A3, NY-ESO-1 or SSX4 expression in this model
might be because these genes are expressed at earlier stages of
differentiation. We believe this because SPANX-B expression is
primarily in post-meiotic cells of the testis (i.e. spermatocytes,
spermatids, or sperm), whereas GAGE, MAGE-A3, NY-ESO-1 or
SSX expression is primarily in spermatogonia [11].
Our data and that of several others’ indicate that cancer cells
that express CT genes have more of an epithelial rather than a
mesenchymal phenotype. We suggest that CT genes PAGE2 and
SPANX-B are induced during a window of differentiation that
correlates with up-regulation of epithelial markers of differentia-
tion. The Caco-2 SD model has made it possible to observe the
actively changing epigenetic landscape within the promoters of
these CT genes. However, as CT gene expression in tumors has
closely been related to the methylation state of their promoter, the
process that leads to CT gene induction in vivo might ultimately
result in ‘‘fixing’’ of the epigenetic state which would in turn result
in CpG methylation. Yet, via dynamic MET in tumors [40], it is
conceivable that even this might change over the course of the
disease.
From a clinical perspective, data from our lab as well as from
others reveal that sub-grouping of tumors based on gene
expression profiles can clearly identify cells with different chemo-
sensitivity profiles [12,41,42]. In this line, we predict future studies
will reveal distinct drug sensitivity profiles for colorectal cancer
subtypes as possibly defined by PAGE2 and SPANX-B expression,
for which the Caco-2 SD model could be used.
Supporting Information
Figure S1 Post-confluence differentiation of Caco-2 in
vitro. Up-regulation of sucrase-isomaltase (A), and carcinoem-
bryonic antigen (CEA) (B) in cells collected at indicated days post
confluence (DPC) as determined by quantitative RT-PCR, and
Western analysis, respectively. Alkaline phosphatase expression is
also upregulated as determined by immunohistochemistry reveal-
ing differentiation (C). Other measures of differentiation for the
cells used in this study have been reported previously (ref. 17).
*P,0.001 (ANOVA with Tukey’s post hoc test).
(DOCX)
Figure S2 Up-regulation of CT gene expression during
Caco-2 spontaneous differentiation in vitro. Heat map
based on 31 probesets in GSE1614 corresponding to 23 CT genes
from 7 families. As compared to proliferating cells, gene expression
incrementally increases in at confluence (8th day) and further
during post-confluence differentiation (15th day).
(DOCX)
Figure S3 Western analysis of differentially expressed
genes during Caco-2 SD. A gradual increase in SPANX-B and
CDX2 in parallel to a decrease in expression of FN, VIM and
TGLN up to day 30 post-confluence. Results from 3 independent
differentiation experiments are shown.
(DOCX)
Figure S4 SPANX-B and Fibronectin expression show
limited overlap in differentiating Caco-2 cells. Immuno-
fluorescent staining of differentiating Caco-2 cells with DAPI
counterstaining reveals a gradual increase in nuclear SPANX-B
(Alexa Fluor 488: green) with a concomitant decrease in
cytoplasmic fibronectin expression (Alexa Fluor 568: red); (206
magnification) (A). Less than 10% of cells expressing SPANX-B
stained for fibronectin at day 0 (B).
(DOCX)
Figure S5 PAGE2, -2B and Vimentin expression are
mutually exclusive in differentiating Caco-2 cells. Immu-
nofluorescent staining of differentiating Caco-2 cells with DAPI
counterstaining reveals a gradual increase in nuclear PAGE2, -2B
(Alexa Fluor 488: green) with a concomitant decrease in
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cytoplasmic vimentin expression (Alexa Fluor 568: red); (206
magnification) (A). Less than 10% of cells showed double
fluorescence when staining was analyzed quantitatively at day 0.
At later time points, none of the cells showed double staining (B).
(DOCX)
Figure S6 PAGE2, -2B and fibronectin expression are
mutually exclusive in differentiating Caco-2 cells. Immu-
nofluorescent staining of differentiating Caco-2 cells with DAPI
counterstaining reveals a gradual increase in nuclear PAGE2, -2B
(Alexa Fluor 488: green) with a concomitant decrease in
cytoplasmic fibronectin expression (Alexa Fluor 568: red); (206
magnification) (A). Less than 15% of cells showed double
fluorescence when staining was analyzed quantitatively at day 0
(B).
(DOCX)
Figure S7 Nuclear co-localization of CDX2 and PAGE2,
-2B in differentiating Caco-2 cells. Immunofluorescent
staining of differentiating Caco-2 cells with DAPI counterstaining
reveals overlapping PAGE2. -2B (Alexa Fluor 488: green) and
CDX2 (Alexa Fluor 568: red) expression; (206magnification) (A).
More than 80% of the cells show double-labeling when analyzed
quantitatively (B).
(DOCX)
Figure S8 Induction of PAGE2,-2B and SPANX-B gene
expression by 5-aza-29-deoxycytidine in HCT116 (top)
and SK-LC-17 cell lines (bottom). Relative mRNA expres-
sion values at indicated time points compared to day 0, as
determined by quantitative RT-PCR are shown.
(DOCX)
Table S1 PCR primers.
(DOCX)
Table S2 Primer locations.
(DOCX)
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